National Amphetamine-Type Stimulant Strategy Background Paper
National Amphetamine-Type Stimulant Strategy Background Paper
National Amphetamine-Type Stimulant Strategy Background Paper
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
118<br />
Table 6.1: Number of clandestine laboratory detections by state and territory, 96/97-05/06<br />
NSW VIC QLD SA WA TAS NT ACT Total<br />
1996-97 a – – – – – – – – 58<br />
1997-98 19 9 55 7 3 2 0 0 95<br />
1998-99 20 4 83 12 8 0 2 2 131<br />
1999-2000 20 18 79 14 17 0 1 1 150<br />
2000-01 42 32 77 24 22 1 3 0 201<br />
2001-02 32 24 138 32 22 3 1 0 252<br />
2002-03 47 19 171 34 36 2 3 2 314<br />
2003-04 61 20 189 48 33 1 6 0 358<br />
2004-05 45 31 209 25b 44 3 21 3 381<br />
2005-06 55 47 161 50 58 5 12 2 390<br />
a. Jurisdictional breakdown unavailable for 1996-97.<br />
Source: ACC, Illicit Drug Data Report 2005-06, Canberra: ACC<br />
6.3 Precursor regulation<br />
<strong>National</strong> initiatives<br />
The nature of the synthetic illicit drug trade is such that law enforcement and policing<br />
strategies are becoming increasingly focused on precursor substances and equipment;<br />
not just the end products of the drugs themselves. In many countries, this has taken the<br />
form of increasingly strict precursor regulations including:<br />
• Criminalising the supply of precursor chemicals for the use of ATS production;<br />
• Limiting the amount of licit drugs allowed to be purchased in pharmacies and over-thecounter;<br />
• Restricting the international and intra-national movement of large quantities of precursor<br />
chemicals; and<br />
• Attempting to monitor the movement and supply of drugs that can be utilised in the<br />
production of ATS (Cherney et al., 2006).<br />
The <strong>National</strong> <strong>Strategy</strong> to Prevent the Diversion of Precursor Chemicals into Illicit Drug<br />
Manufacture (the “<strong>National</strong> Precursor <strong>Strategy</strong>”) provides the strategic framework for the<br />
initiatives undertaken by the <strong>National</strong> Working Group on the Prevention of the Diversion of<br />
Precursor Chemicals into Illicit Drug Manufacture (the “<strong>National</strong> Precursor Working Group”).<br />
Comprised of representatives of state and territory, health agencies, forensic services and<br />
the private sector this forum is a key mechanism for formulating effective cross-sector,<br />
nationally coordinated and consistent responses to precursor diversion (see Table 6.2).